|
1
|
Arzumanyan A, Reis HM and Feitelson MA:
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular
carcinoma. Nat Rev Cancer. 13:123–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim DY and Han KH: Epidemiology and
surveillance of hepatocellular carcinoma. Liver Cancer. 1:2–14.
2012. View Article : Google Scholar
|
|
3
|
Shirabe K, Mano Y, Muto J, et al: Role of
tumor-associated macrophages in the progression of hepatocellular
carcinoma. Surg Today. 42:1–7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang YY, Lo GH, Lai KH, et al: Increased
serum concentrations of tumor necrosis factor-α are associated with
disease progression and malnutrition in hepatocellular carcinoma. J
Chin Med Assoc. 66:592–597. 2003.
|
|
5
|
Ding J, Huang S, Wang Y, et al:
Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB
pathway by down-regulating IκB kinase alpha and TAB3 in
hepatocellular carcinoma. Hepatology. 58:654–666. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Teixeira AC, Mendes CT Jr, Marano LA, et
al: Alleles and genotypes of polymorphisms of IL-18, TNF-α and
IFN-γ are associated with a higher risk and severity of
hepatocellular carcinoma (HCC) in Brazil. Hum Immunol.
74:1024–1029. 2013. View Article : Google Scholar
|
|
7
|
Rucci N, Sanità P and Angelucci A: Roles
of metalloproteases in metastatic niche. Curr Mol Med. 11:609–622.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilken R, Veena MS, Wang MB, et al: A
review of anti-cancer properties and therapeutic activity in head
and neck squamous cell carcinoma. Mol Cancer. 10:122011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stokes A, Joutsa J, Ala-Aho R, et al:
Expression profiles and clinical correlations of degradome
components in the tumor microenvironment of head and neck squamous
cell carcinoma. Clin Cancer Res. 16:2022–2035. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu D, Guo H, Li Y, et al: Association
between polymorphisms in the promoter regions of matrix
metalloproteinases (MMPs) and risk of cancer metastasis: a
meta-analysis. PLoS One. 7:e312512012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang M, Dai C, Zhu H, et al: Cyclophilin
A promotes human hepatocellular carcinoma cell metastasis via
regulation of MMP3 and MMP9. Mol Cell Biochem. 357:387–395. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okamoto K, Ishida C, Ikebuchi Y, et al:
The genotypes of IL-1 beta and MMP-3 are associated with the
prognosis of HCV-related hepatocellular carcinoma. Intern Med.
49:887–895. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nannuru KC, Futakuchi M, Varney ML, et al:
Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced
osteolysis by activating MMP9 and transforming growth factor-beta
signaling at the tumor-bone interface. Cancer Res. 70:3494–3504.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pivetta E, Scapolan M, Pecolo M, et al:
MMP-13 stimulates osteoclast differentiation and activation in
tumour breast bone metastases. Breast Cancer Res. 13:R1052011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kudo Y, Iizuka S, Yoshida M, et al: Matrix
metalloproteinase-13 (MMP-13) directly and indirectly promotes
tumor angiogenesis. J Biol Chem. 287:38716–38728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun H, Gong S, Carmody RJ, et al: TIPE2, a
negative regulator of innate and adaptive immunity that maintains
immune homeostasis. Cell. 133:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang G, Zhang W, Lou Y, et al: TIPE2
deficiency accelerates neointima formation by downregulating smooth
muscle cell differentiation. Cell Cycle. 12:501–510. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gus-Brautbar Y, Johnson D, Zhang L, et al:
The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.
Mol Cell. 45:610–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ke SZ, Ni XY, Zhang YH, et al:
Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by
activating the ATM/NF-κB pathway in lung cancer cells. Int J Oncol.
42:1289–1296. 2013.PubMed/NCBI
|
|
20
|
Jin HJ, Sui HX, Wang YN, et al: Nicotine
up-regulated 4-1BBL expression by activating Mek-PI3K pathway
augments the efficacy of bone marrow-derived dendritic cell
vaccination. J Clin Immunol. 33:246–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin HJ, Li HT, Sui HX, et al: Nicotine
stimulated bone marrow-derived dendritic cells could augment HBV
specific CTL priming by activating PI3K-Akt pathway. Immunol Lett.
146:40–49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao FG, Li HT, Li ZJ, et al: Nicotine
stimulated dendritic cells could achieve anti-tumor effects in
mouse lung and liver cancer. J Clin Immunol. 31:80–88. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Xu X, Bai L, et al: Epidermal growth
factor receptor-mediated tissue transglutaminase overexpression
couples acquired tumor necrosis factor-related apoptosis-inducing
ligand resistance and migration through c-FLIP and MMP-9 proteins
in lung cancer cells. J BiolChem. 286:21164–21172. 2011.
|
|
24
|
Lin X, Zheng W, Liu J, et al: Oxidative
stress in malignant melanoma enhances tumor necrosis factor-α
secretion of tumor-associated macrophages that promote cancer cell
invasion. Antioxid Redox Signal. 19:1337–1355. 2013. View Article : Google Scholar
|
|
25
|
Sakai T, Liu L, Teng X, et al:
Inflammatory disease and cancer with a decrease in Kupffer cell
numbers in Nucling-knockout mice. Int J Cancer. 126:1079–1094.
2010.PubMed/NCBI
|
|
26
|
Kim MJ, Jang JW, Oh BS, et al: Change in
inflammatory cytokine profiles after transarterial chemotherapy in
patients with hepatocellular carcinoma. Cytokine. 64:516–522. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Budhu A, Forgues M, Ye QH, et al:
Prediction of venous metastases, recurrence, and prognosis in
hepatocellular carcinoma based on a unique immune response
signature of the liver microenvironment. Cancer Cell. 10:99–111.
2006. View Article : Google Scholar
|
|
28
|
Lee EJ, Kim WJ and Moon SK: Cordycepin
suppresses TNF-alpha-induced invasion, migration and matrix
metalloproteinase-9 expression in human bladder cancer cells.
Phytother Res. 24:1755–1761. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kroesen S, Widmer AF, Tyndall A, et al:
Serious bacterial infections in patients with rheumatoid arthritis
under anti-TNF-α therapy. Rheumatology. 42:617–621. 2003.
View Article : Google Scholar
|
|
30
|
Fabian D, Juhás S, Il’ková G, et al: Dose-
and time-dependent effects of TNFα and actinomycin D on cell death
incidence and embryo growth in mouse blastocysts. Zygote.
15:241–249. 2007. View Article : Google Scholar
|
|
31
|
Radhakrishnan P, Chachadi V, Lin MF, et
al: TNFα enhances the motility and invasiveness of prostatic cancer
cells by stimulating the expression of selective glycosyl- and
sulfotransferase genes involved in the synthesis of selectin
ligands. Biochem Biophys Res Commun. 409:436–441. 2011. View Article : Google Scholar
|
|
32
|
Ferrajoli A, Keating MJ, Manshouri T, et
al: The clinical significance of tumor necrosis factor-α plasma
level in patients having chronic lymphocytic leukemia. Blood.
100:1215–1219. 2002.
|
|
33
|
Ye S, Eriksson P, Hamsten A, et al:
Progression of coronary atherosclerosis is associated with a common
genetic variant of the human stromelysin-1 promoter which results
in reduced gene expression. J Biol Chem. 271:13055–13060. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Altadill A, Rodríguez M, González LO, et
al: Liver expression of matrix metalloproteases and their
inhibitors in hepatocellular carcinoma. Dig Liver Dis. 41:740–748.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Smith EC, Teixeira AM, Chen RC, et al:
Induction of mega-karyocyte differentiation drives nuclear
accumulation and transcriptional function of MKL1 via actin
polymerization and RhoA activation. Blood. 121:1094–1101. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hao YH, Doyle JM, Ramanathan S, et al:
Regulation of WASH-dependent actin polymerization and protein
trafficking by ubiquitination. Cell. 152:1051–1064. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang S, Wen F, Wiley GB, et al: An
enhancer element harboring variants associated with systemic lupus
erythematosus engages the TNFAIP3 promoter to influence A20
expression. PLoS Genet. 9:e10037502013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wertz IE, O’Rourke KM, Zhou H, et al:
De-ubiquitination and ubiquitin ligase domains of A20 downregulate
NF-kappaB signalling. Nature. 430:694–699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Skaug B, Chen J, Du F, et al: Direct,
noncatalytic mechanism of IKK inhibition by A20. Mol Cell.
44:559–571. 2011. View Article : Google Scholar : PubMed/NCBI
|
